How much is a health insurer willing to pay for Colorectal Cancer screening tests?

How much is a health insurer willing to pay for Colorectal Cancer screening tests?

Colorectal Cancer (CRC) screening tests have proven to be cost-effective in preventing cancer incidence. Yet, as recent studies have shown, CRC screening tests are noticeably underutilized. Among the factors influencing CRC screening test utilization, the role of health insurers has gained considera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yaesoubi, Reza, Roberts, Stephen D.
Format: Tagungsbericht
Sprache:eng
Schlagworte:
Aging
Cancer detection
Colon
Costs
Cyclic redundancy check
Diseases
Insurance
Life estimation
Life testing
Systems engineering and theory
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1631
container_issue
container_start_page 1624
container_title
container_volume
creator Yaesoubi, Reza
Roberts, Stephen D.
description Colorectal Cancer (CRC) screening tests have proven to be cost-effective in preventing cancer incidence. Yet, as recent studies have shown, CRC screening tests are noticeably underutilized. Among the factors influencing CRC screening test utilization, the role of health insurers has gained considerable attention in recent studies. In this paper, we propose an analytical model for the market of CRC screening tests and show how the insurer can benefit from a computer simulation model to cope with the problem of incomplete and asymmetric information inherent in this market. Our estimates reveal that promoting CRC screening tests is not necessarily economically attractive to the insurer, unless the insurer's valuation of life is greater than a certain limit. We use the proposed model to estimate such a threshold - the insurer's willingness-to-pay to acquire one additional life year by covering the CRC screening tests.
doi_str_mv 10.1109/WSC.2008.4736246
format Conference Proceeding
fullrecord <record><control><sourceid>ieee_6IE</sourceid><recordid>TN_cdi_ieee_primary_4736246</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ieee_id>4736246</ieee_id><sourcerecordid>4736246</sourcerecordid><originalsourceid>FETCH-LOGICAL-i175t-6d30b22412fb52553136f73817e6ceee9f72b5aa7bb586351ddfcb004c045be43</originalsourceid><addsrcrecordid>eNpVkE1LAzEYhONHwbX2LnjJH9g1b5I3yZ5EFrVCQfADjyVJs3Zlu1uSLaX_3kV78TQD88wchpBrYAUAK28_36qCM2YKqYXiUp2QWakNSC4l18yoU5IBosmlYHj2L9PlOcmYKSHXY3VCMqNzhRIMvyCXKX0zBgaBZ-R13u_pZufXtEnU0nWw7TD6Lu1iiHTftG3TfdGhp1t7oHUfadW3fQx-sC2tbOdHKPkYQveLhTSkuysyqW2bwuyoU_Lx-PBezfPFy9Nzdb_IG9A45GolmONcAq8dckQBQtVaGNBB-RBCWWvu0FrtHBolEFar2jvGpGcSXZBiSm7-dpuRXm5js7HxsDxeJX4AZYZV4A</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>How much is a health insurer willing to pay for Colorectal Cancer screening tests?</title><source>IEEE Electronic Library (IEL) Conference Proceedings</source><creator>Yaesoubi, Reza ; Roberts, Stephen D.</creator><creatorcontrib>Yaesoubi, Reza ; Roberts, Stephen D.</creatorcontrib><description>Colorectal Cancer (CRC) screening tests have proven to be cost-effective in preventing cancer incidence. Yet, as recent studies have shown, CRC screening tests are noticeably underutilized. Among the factors influencing CRC screening test utilization, the role of health insurers has gained considerable attention in recent studies. In this paper, we propose an analytical model for the market of CRC screening tests and show how the insurer can benefit from a computer simulation model to cope with the problem of incomplete and asymmetric information inherent in this market. Our estimates reveal that promoting CRC screening tests is not necessarily economically attractive to the insurer, unless the insurer's valuation of life is greater than a certain limit. We use the proposed model to estimate such a threshold - the insurer's willingness-to-pay to acquire one additional life year by covering the CRC screening tests.</description><identifier>ISSN: 0891-7736</identifier><identifier>ISBN: 9781424427079</identifier><identifier>ISBN: 142442707X</identifier><identifier>EISSN: 1558-4305</identifier><identifier>EISBN: 9781424427086</identifier><identifier>EISBN: 1424427088</identifier><identifier>DOI: 10.1109/WSC.2008.4736246</identifier><identifier>LCCN: 87-654182</identifier><language>eng</language><publisher>IEEE</publisher><subject>Aging ; Cancer detection ; Colon ; Costs ; Cyclic redundancy check ; Diseases ; Insurance ; Life estimation ; Life testing ; Systems engineering and theory</subject><ispartof>2008 Winter Simulation Conference, 2008, p.1624-1631</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://ieeexplore.ieee.org/document/4736246$$EHTML$$P50$$Gieee$$H</linktohtml><link.rule.ids>309,310,777,781,786,787,2052,27906,54901</link.rule.ids><linktorsrc>$$Uhttps://ieeexplore.ieee.org/document/4736246$$EView_record_in_IEEE$$FView_record_in_$$GIEEE</linktorsrc></links><search><creatorcontrib>Yaesoubi, Reza</creatorcontrib><creatorcontrib>Roberts, Stephen D.</creatorcontrib><title>How much is a health insurer willing to pay for Colorectal Cancer screening tests?</title><title>2008 Winter Simulation Conference</title><addtitle>WSC</addtitle><description>Colorectal Cancer (CRC) screening tests have proven to be cost-effective in preventing cancer incidence. Yet, as recent studies have shown, CRC screening tests are noticeably underutilized. Among the factors influencing CRC screening test utilization, the role of health insurers has gained considerable attention in recent studies. In this paper, we propose an analytical model for the market of CRC screening tests and show how the insurer can benefit from a computer simulation model to cope with the problem of incomplete and asymmetric information inherent in this market. Our estimates reveal that promoting CRC screening tests is not necessarily economically attractive to the insurer, unless the insurer's valuation of life is greater than a certain limit. We use the proposed model to estimate such a threshold - the insurer's willingness-to-pay to acquire one additional life year by covering the CRC screening tests.</description><subject>Aging</subject><subject>Cancer detection</subject><subject>Colon</subject><subject>Costs</subject><subject>Cyclic redundancy check</subject><subject>Diseases</subject><subject>Insurance</subject><subject>Life estimation</subject><subject>Life testing</subject><subject>Systems engineering and theory</subject><issn>0891-7736</issn><issn>1558-4305</issn><isbn>9781424427079</isbn><isbn>142442707X</isbn><isbn>9781424427086</isbn><isbn>1424427088</isbn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2008</creationdate><recordtype>conference_proceeding</recordtype><sourceid>6IE</sourceid><sourceid>RIE</sourceid><recordid>eNpVkE1LAzEYhONHwbX2LnjJH9g1b5I3yZ5EFrVCQfADjyVJs3Zlu1uSLaX_3kV78TQD88wchpBrYAUAK28_36qCM2YKqYXiUp2QWakNSC4l18yoU5IBosmlYHj2L9PlOcmYKSHXY3VCMqNzhRIMvyCXKX0zBgaBZ-R13u_pZufXtEnU0nWw7TD6Lu1iiHTftG3TfdGhp1t7oHUfadW3fQx-sC2tbOdHKPkYQveLhTSkuysyqW2bwuyoU_Lx-PBezfPFy9Nzdb_IG9A45GolmONcAq8dckQBQtVaGNBB-RBCWWvu0FrtHBolEFar2jvGpGcSXZBiSm7-dpuRXm5js7HxsDxeJX4AZYZV4A</recordid><startdate>200812</startdate><enddate>200812</enddate><creator>Yaesoubi, Reza</creator><creator>Roberts, Stephen D.</creator><general>IEEE</general><scope>6IE</scope><scope>6IH</scope><scope>CBEJK</scope><scope>RIE</scope><scope>RIO</scope></search><sort><creationdate>200812</creationdate><title>How much is a health insurer willing to pay for Colorectal Cancer screening tests?</title><author>Yaesoubi, Reza ; Roberts, Stephen D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i175t-6d30b22412fb52553136f73817e6ceee9f72b5aa7bb586351ddfcb004c045be43</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aging</topic><topic>Cancer detection</topic><topic>Colon</topic><topic>Costs</topic><topic>Cyclic redundancy check</topic><topic>Diseases</topic><topic>Insurance</topic><topic>Life estimation</topic><topic>Life testing</topic><topic>Systems engineering and theory</topic><toplevel>online_resources</toplevel><creatorcontrib>Yaesoubi, Reza</creatorcontrib><creatorcontrib>Roberts, Stephen D.</creatorcontrib><collection>IEEE Electronic Library (IEL) Conference Proceedings</collection><collection>IEEE Proceedings Order Plan (POP) 1998-present by volume</collection><collection>IEEE Xplore All Conference Proceedings</collection><collection>IEEE Electronic Library (IEL)</collection><collection>IEEE Proceedings Order Plans (POP) 1998-present</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Yaesoubi, Reza</au><au>Roberts, Stephen D.</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>How much is a health insurer willing to pay for Colorectal Cancer screening tests?</atitle><btitle>2008 Winter Simulation Conference</btitle><stitle>WSC</stitle><date>2008-12</date><risdate>2008</risdate><spage>1624</spage><epage>1631</epage><pages>1624-1631</pages><issn>0891-7736</issn><eissn>1558-4305</eissn><isbn>9781424427079</isbn><isbn>142442707X</isbn><eisbn>9781424427086</eisbn><eisbn>1424427088</eisbn><abstract>Colorectal Cancer (CRC) screening tests have proven to be cost-effective in preventing cancer incidence. Yet, as recent studies have shown, CRC screening tests are noticeably underutilized. Among the factors influencing CRC screening test utilization, the role of health insurers has gained considerable attention in recent studies. In this paper, we propose an analytical model for the market of CRC screening tests and show how the insurer can benefit from a computer simulation model to cope with the problem of incomplete and asymmetric information inherent in this market. Our estimates reveal that promoting CRC screening tests is not necessarily economically attractive to the insurer, unless the insurer's valuation of life is greater than a certain limit. We use the proposed model to estimate such a threshold - the insurer's willingness-to-pay to acquire one additional life year by covering the CRC screening tests.</abstract><pub>IEEE</pub><doi>10.1109/WSC.2008.4736246</doi><tpages>8</tpages></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0891-7736
ispartof 2008 Winter Simulation Conference, 2008, p.1624-1631
issn 0891-7736
1558-4305
language eng
recordid cdi_ieee_primary_4736246
source IEEE Electronic Library (IEL) Conference Proceedings
subjects Aging
Cancer detection
Colon
Costs
Cyclic redundancy check
Diseases
Insurance
Life estimation
Life testing
Systems engineering and theory
title How much is a health insurer willing to pay for Colorectal Cancer screening tests?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T10%3A58%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-ieee_6IE&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=How%20much%20is%20a%20health%20insurer%20willing%20to%20pay%20for%20Colorectal%20Cancer%20screening%20tests?&rft.btitle=2008%20Winter%20Simulation%20Conference&rft.au=Yaesoubi,%20Reza&rft.date=2008-12&rft.spage=1624&rft.epage=1631&rft.pages=1624-1631&rft.issn=0891-7736&rft.eissn=1558-4305&rft.isbn=9781424427079&rft.isbn_list=142442707X&rft_id=info:doi/10.1109/WSC.2008.4736246&rft_dat=%3Cieee_6IE%3E4736246%3C/ieee_6IE%3E%3Curl%3E%3C/url%3E&rft.eisbn=9781424427086&rft.eisbn_list=1424427088&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_ieee_id=4736246&rfr_iscdi=true